1869912-39-9
Chemical Structure
AZD5153
- CAS No.: 1869912-39-9
- Formula:C25H33N7O3
- Molecular Weight:479.57
IUPAC Name: (R)-4-(2-(4-(1-(3-methoxy-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)piperidin-4-yl)phenoxy)ethyl)-1,3-dimethylpiperazin-2-one
InChIKey: RSMYFSPOTCDHHJ-GOSISDBHSA-N
SMILES: O=C1N(C)CCN(CCOC2=CC=C(C3CCN(C4=NN5C(C=C4)=NN=C5OC)CC3)C=C2)[C@@H]1C
Biological Activity: AZD5153 is a bivalent, selective, and orally active BET/BRD4 bromodomain inhibitor with an IC50 of value of 5 nM for full-length BRD4 (FL-BRD4). AZD5153 ligates two bromodomains in BRD4 simultaneously. AZD5153 can be used for the study of cancer, such as acute myeloid leukemia, multiple myeloma, and diffuse large B-cell lymphoma[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
AZD5153 | 99.89% | AZD5153 is a bivalent, selective, and orally active BET/BRD4 bromodomain inhibitor with an IC50 of value of 5 nM for full-length BRD4 (FL-BRD4). AZD5153 ligates two bromodomains in BRD4 simultaneously. AZD5153 can be used for the study of cancer, such as acute myeloid leukemia, multiple myeloma, and diffuse large B-cell lymphoma. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 0.78
HY-100653ARAZD5153 6-Hydroxy-2-naphthoic acid (Standard) -
Similarity Score 0.68
HY-123626BiBET -
Similarity Score 0.48
HY-146455DPP-4-IN-3 -
Similarity Score 0.47
HY-175604SCL-1 -
Similarity Score 0.46
HY-13784Pirodavir -
Similarity Score 0.46
HY-120594R78206 -
Similarity Score 0.46
HY-162022BTA-188 -
Similarity Score 0.46
HY-176063TRPV1 antagonist 11 -
Similarity Score 0.45
HY-158776SLU-10482 -
Explore the MedChemAI to find more analogs
